GlassScriptPhysician profile
Sheena Khan
NPI 1609186360
$2,128.68
in general payments reported to CMS, 2019-2025
34 companies · $436 in 2025
The $436 reported for 2025 was more than what 75% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $448 · 2020: $176 · 2021: $124 · 2022: $223 · 2023: $475 · 2024: $246 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $315.46 | 2021-2025 | Phexxi, Solosec, Phexx |
| Abbvie INC. | $258.01 | 2019-2025 | |
| Astellas Pharma US INC | $186.00 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $182.44 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $150.75 | 2019-2025 | |
| Biogen, INC. | $87.53 | 2025 | Zurzuvae |
| Organon LLC | $85.54 | 2023-2025 | Jada System, Nuvaring, Nexplanon |
| Pfizer INC. | $81.39 | 2019-2023 | |
| Coopersurgical, INC. | $64.40 | 2019-2020 | |
| Meditrina | $61.06 | 2022-2024 | |
| Smith+Nephew, INC. | $55.77 | 2019-2024 | Acticoat 4" X 4", Pico 7, Pico 14 |
| Exeltis, USA INC. | $51.57 | 2020-2023 | Slynd |
| Daiichi Sankyo INC. | $50.80 | 2019 | |
| Hologic Sales and Service, LLC | $48.50 | 2019-2023 | Aptima, Thinprep 2000 Processor |
| Avion Pharmaceuticals | $46.73 | 2019-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $42.59 | 2023-2025 | Myfembree |
| Dysis Medical, INC. | $39.89 | 2019 | |
| Allergan, INC. | $30.69 | 2019 | |
| Amag Pharmaceuticals, INC. | $28.03 | 2019 | |
| Millicent US INC | $27.72 | 2019-2020 | |
| Therapeuticsmd, INC. | $27.25 | 2019 | |
| Myovant Sciences INC. | $25.34 | 2022 | |
| Agile Therapeutics, INC. | $21.61 | 2023 | Twirla |
| Shield Therapeutics INC | $18.85 | 2024 | |
| Olympus America INC. | $16.82 | 2022 | |
| Duchesnay USA Incorporated | $16.26 | 2019 | |
| Merck Sharp & Dohme LLC | $15.29 | 2023 | Gardasil 9 |
| Ethicon US, LLC | $15.14 | 2020 | |
| Vertical Pharmaceuticals, LLC | $14.77 | 2019 | |
| Kci USA, INC. | $14.04 | 2023 | Prevena |
| Aspira Women'S Health INC | $13.57 | 2021 | |
| Mission Pharmacal Company | $13.54 | 2019 | |
| Mylan Pharmaceuticals INC. | $12.76 | 2019 | |
| Channel Medsystems, INC. | $8.57 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheena Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.